PERSPECTA

News from every angle

Back to headlines

Spain Launches First Human Trial for TET101 Gene Therapy Targeting Alzheimer’s

Neuroscientist Álvaro Pascual-Leone announces the inaugural human trials for TET101, a novel gene therapy designed to halt disease progression and restore lost cognitive functions in Alzheimer’s patients.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.